Enliven Therapeutics Announces Poster Presentations at the 2025 AACR Annual Meeting
Provided By PR Newswire
Last update: Apr 2, 2025
BOULDER, Colo., April 2, 2025 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced the Company will present five posters at the upcoming American Association for Cancer Research (AACR) Annual Meeting, taking place April 25-30, 2025, in Chicago, Illinois.
Read more at prnewswire.com
